Posted on 5/21/18
Akari Therapeutics Receives Notice Related to Delay in 20-F Filing
NEW YORK and LONDON, May 21, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics . . .
Posted on 5/21/18
Phreesia Selected as one of Modern Healthcare's "Best Places to Work in Healthcare" for the Third Year in a Row
Phreesia, the nation's leading patient intake management platform, has been named one of Modern Healthcare magazine's Best Places to Work in Healthcare for the third consecutive . . .
Posted on 5/21/18
Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
MINNEAPOLIS-ST. PAUL, Minn. & NEW YORK--(BUSINESS WIRE)--Cellectis S.A. (Paris:ALCLS) (NASDAQ:CLLS) and Calyxt, Inc. (NASDAQ: CLXT) announced that the underwriters of Calyxt’s previously announced follow-on offering have . . .
Posted on 5/21/18
Bioasis and WuXi Biologics Announce Initial Strategic Collaboration
RICHMOND, British Columbia & GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (TSX.V:BTI; OTCQB:BIOAF) and WUXI BIOLOGICS (2269.HK) today announced an initial strategic collaboration for the development . . .
Posted on 5/21/18
J&J Gets Rid Of Drug For Alzheimer's, But Remains Strong With Oncology Business
Recently, Johnson & Johnson (JNJ) announced that it would axe its Alzheimer's drug atabecestat. This move is another blow to a pharmaceutical company seeking to find . . .
Posted on 5/18/18
Forget Cara Therapeutics' Earnings -- Here's the Real News
Ordinarily, a report of zero revenue in a quarter would not be too well received by investors. That was exactly the top-line result for Cara Therapeutics . . .
Posted on 5/17/18
Johnson & Johnson (JNJ) Investor Presentation - Slideshow
The following slide deck was published by Johnson & Johnson in conjunction with this event.READ FULL ARTICLE HERE
Posted on 5/17/18
Rocket Pharmaceuticals Announces Strategic Research Collaboration
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic . . .
Posted on 5/17/18
Abeona Reports Update from EB-101 Gene Therapy in Epidermolysis Bullosa at 21st Annual ASGCT Meeting
NEW YORK and CLEVELAND, May 17, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene . . .
Posted on 5/17/18
Iterum Therapeutics Readies $80 Million IPO Plans
Quick TakeIterum Therapeutics (ITRM) intends to raise $80 million in an IPO from the sale of common stock, per an amended registration statement.The company is developing . . .
Posted on 5/17/18
Generic Revlimid Could Sink Celgene
Blow ups in its Celgene's (CELG) R&D pipeline have caused bulls to question the company's future growth. Generic drug makers could now pose challenges to Revlimid, . . .
Posted on 5/17/18
Celgene's (CELG) Management Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)
Celgene Corporation (NASDAQ:CELG) Bank of America Merrill Lynch Healthcare Conference Call May 16, 2018 1:00 PM ETExecutivesPeter Kellogg - Chief Financial OfficerAnalystsYing Huang - Bank of . . .
Posted on 5/17/18
TikaMobile Selected by TherapeuticsMD as Business Intelligence Platform Provider
NEW YORK, May 16, 2018 (GLOBE NEWSWIRE) -- TikaMobile, Inc. a cloud-based analytics and CRM technology company for the life sciences industry, today announced that it . . .
Posted on 5/16/18
M Science Wins Benzinga Global Fintech Award
NEW YORK--(BUSINESS WIRE)--M Science, the leader in data-driven research and analytics, today announced winning the award in the Finding Alpha Through Alternative Data category at the . . .
Posted on 5/16/18
Newport Credentialing Solutions Ranks No. 1 Among Credentialing and Privileging Firms in Black Book Survey
CHATTANOOGA, Tenn. & LYNBROOK, N.Y.--(BUSINESS WIRE)--Newport Credentialing Solutions, a division of TractManager, Inc., is the top-ranked provider of credentialing and privileging solutions in a second-quarter 2018 . . .
Posted on 5/15/18
MTBC Reports First Quarter 2018 Results
SOMERSET, N.J , May 15, 2018 (GLOBE NEWSWIRE) -- MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced . . .
Posted on 5/15/18
Celgene Starts the Year With a Bang
Celgene (NASDAQ:CELG) started the year off with a solid first quarter, leading management to raise its 2018 guidance already.Celgene results: The raw numbers MetricQ1 2018Q1 2017Year-Over-Year . . .
Posted on 5/15/18
Oncobiologics Announces $15 Million Private Placement Offering
CRANBURY, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that on May 11, 2018, it entered into a purchase agreement . . .
Posted on 5/14/18
Formativ Health Named Silver Stevie Award Winner in 2018 American Business Awards
NEW YORK--(BUSINESS WIRE)--Formativ Health, a technology-enabled health services company focused on transforming the patient-provider experience, announced today the company was named the winner of a Silver . . .
Posted on 5/14/18
Medical Offices of Manhattan (MOM)/Manhattan Cardiology Announce Acquisition of Yaffe Ruden & Associates
Medical Offices of Manhattan (MOM) and Manhattan Cardiology, top integrated medical practices with primary care physicians and cardiologists,
Posted on 5/14/18
Synergy Pharmaceuticals: The Short Covering Has Begun
For many shareholders, Q1 results might seem like the reason they were looking for to bail on their investment at Synergy Pharmaceuticals (SGYP) and shorts know . . .
Posted on 5/14/18
Pharmacy Times Named Industry News Provider of the Year by American Pharmacy Purchasing Alliance
CRANBURY, N.J.--(BUSINESS WIRE)--Pharmacy Times®, the leading media resource for pharmacists and the pharmacy industry, has been named the 2018 Industry News Provider of the Year by . . .
Posted on 5/11/18
Regeneron: Initiating At These Levels
Regeneron Pharmaceuticals (REGN) has seen continued struggles after a spectacular run higher from 2010 onward. Shares rose from $25 that year to $550 late in 2015, . . .
Posted on 5/11/18
Zelis Healthcare and MD Insider Announce Partnership
BEDMINSTER, N.J. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Zelis Healthcare, a market-leading healthcare technology company, today announced a strategic partnership with MD Insider to enhance network analytics capabilities . . .
Posted on 5/10/18
Bellerophon Provides Business Update
WARREN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and . . .

